Postgastrectomy anticancer chemotherapy for stage IV gastric cancer equally tolerable for patients under and over age 65

Y. Maehara, I. Takahashi, M. Yoshida, H. Baba, H. Kusumoto, H. Anai, K. Sugimachi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We compared the survival time and drug toxicity between patients with stage IV gastric cancer who were over and under 65 years. All had undergone gastric resection followed by treatment with mitomycin C and a fluorinated pyrimidine. There were no differences in prognostic factors or doses of drugs prescribed between the two groups, nor were there differences in survival rates or toxicities. As advanced chronological age is not sufficient justification to limit or withhold treatment with anticancer drugs, postoperative chemotherapy should be designed for patients with gastric cancer, regardless of age.

Original languageEnglish
Pages (from-to)27-29
Number of pages3
JournalAnticancer research
Volume13
Issue number1
Publication statusPublished - Jan 1 1993

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Postgastrectomy anticancer chemotherapy for stage IV gastric cancer equally tolerable for patients under and over age 65'. Together they form a unique fingerprint.

  • Cite this

    Maehara, Y., Takahashi, I., Yoshida, M., Baba, H., Kusumoto, H., Anai, H., & Sugimachi, K. (1993). Postgastrectomy anticancer chemotherapy for stage IV gastric cancer equally tolerable for patients under and over age 65. Anticancer research, 13(1), 27-29.